Henry Schein said global net sales decreased 0.1% for the 3 months ended March 29, 2025. It explained that internally generated local currency sales increased 0.2%.

1. 01

   Henry Schein said global net sales decreased 0.1% for the 3 months ended March 29, 2025. It explained that internally generated local currency sales increased 0.2%.

2. 02

   The company said sales of PPE products and COVID-19 test kits for the 3 months ended March 29, 2025 were estimated at $163 million, representing a net decrease of approximately $17 million compared to $180 million in the prior-year period.

3. 03

   Henry Schein said net cash provided by operating activities for the 3 months ended March 29, 2025 was $37 million (compared to $197 million in the prior year), and net cash used in investing activities was $99 million (compared to $72 million in the prior year).

4. 04

   The company said the effective tax rate for the 3 months ended March 29, 2025 was 24.9%. It added that restructuring charges associated with the 2024 restructuring plan were $25 million, consisting primarily of severance and employee-related costs.

Key figures

Quarter ended March 29, 2025

Revenue

$3.2B

Operating income

$175M

Net income

$110M

EPS

$0.88

Gross profit

$1.0B

Operating cash flow

$37M

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.